Hyper-Recornbination and Bloom's Syndrome: Microbes Again Provide Clues About Cancer Rodney Rothstein and Serge Gangloff

Total Page:16

File Type:pdf, Size:1020Kb

Hyper-Recornbination and Bloom's Syndrome: Microbes Again Provide Clues About Cancer Rodney Rothstein and Serge Gangloff Downloaded from genome.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Hyper-recornbination and Bloom's Syndrome: Microbes Again Provide Clues about Cancer Rodney Rothstein and Serge Gangloff Department of Genetics and Development, Columbia University College of Physicians and Surgeons, New York, New York 10032 Once again, a gene family first identified in mi- microbes and man that specifically increase re- croorganisms has been linked to human cancer combination. predisposition. The first in a series of intriguing links between microbial genetics and tumorigen- esis in man emerged when the genes responsible Bloom's Syndrome for xeroderma pigmentosum were identified as Bloom's syndrome, originally identified as a dis- homologs of yeast DNA repair genes (for review, tinct erythematous facial rash (Bloom 1954), is see Cleaver 1994; Tanaka and Wood 1994). An- inherited as an autosomal recessive trait. In addi- other link surfaced 2 years ago with the identifi- tion, individuals affected with Bloom's syndrome cation of human colorectal cancer susceptibility are characterized by growth retardation, abnor- and mutations in a homolog of a bacterial and mal spermatogenesis, and an elevated risk of de- yeast mismatch repair gene (Fishel et al. 1993; veloping cancer (German 1993). Besides these Parsons et al. 1993). Earlier this year, the gene clinical manifestations, cells from individuals responsible for ataxia-telangiectasia was identi- with Bloom's syndrome exhibit elevated levels of fied as a member of a kinase gene family that may chromosome breaks and gaps, somatic cross- play a role in DNA damage recognition (Green- overs, and sister chromatid exchange (German well et al. 1995; Hari et al. 1995; Morrow et al. 1995; Savitsky et al. 1995). The latest link is the 1993). Genetic experiments with Bloom's syndrome identification of the Bloom's syndrome gene, cell lines showed that transfer of chromosome 15 BLM (Ellis et a]. 1995a). BLM encodes a protein could complement increased sister chromatid ex- homologous to the RecQ/Sgsl DNA helicase sub- change. Further refinements in the genetic map family first identified in bacteria and yeast localized the defective gene to a region near (Umezu et al. 1990; Gangloff et al. 1994). Muta- 15q26.1 (Ellis et al. 1994). An important break- tions in BLM and in the yeast homolog SGS1 con- through came when German's group found that fer the common phenotype of hyper-recom- they could exploit an early observation. They no- bination to cells. ticed that although most cells of individuals with Hyper-recombination collectively refers to Bloom's syndrome exhibit high sister chromatid any cellular state in which the frequency of ge- exchange, there exists a minor population of netic exchange is elevated. The exchanges can lymphocytes with low sister chromatid ex- occur, for example, between sister chromatids, al- change. Cells with low sister chromatid exchange lelic genes, or repetitive DNA sequences scattered were predominantly found in individuals whose throughout the genome. The frequency of re- parental alleles were not identical by descent and combination can be measured genetically be- therefore contained different mutations in BLM. tween marked intervals and also cytologically as An intragenic crossover between the paternal and deletions, inversions, translocations, sister chro- maternal alleles generated a wild-type gene on matid exchanges, and somatic crossovers. In this one chromosome and a gene containing both pa- review we limit our discussion to mutations in rental mutations on the homologous chromo- some. After segregation, half of the recombined cell lines became homozygous for polymorphic ~Corresponding author. markers distal to the BLM locus, whereas they E-MAIL [email protected]; FAX (212) 923- 2090. remained heterozygous for polymorphic markers 5:421-426 @1995 by Cold Spring Harbor Laboratory Press ISSN 1054-9803/95 $5.00 GENOME RESEARCH ~ 421 Downloaded from genome.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press ROTHSTEIN AND GANGLOFF proximal to the locus (Ellis et al. 1995b). Thus, that its protein sequence shared significant ho- somatic crossover point mapping helped demar- mology with bacterial RecQ. In addition, another cate the boundaries of the gene and narrow down RecQ homolog has been identified as a result of the chromosomal region. It is interesting to note the Caenorhabditis elegans sequencing project that the hyper-recombinogenic nature of the bhn (GenBank no. U00052, K02F3.1). To date, no dis- mutation probably led to the high incidence of ease mapping to the human RECQL gene ho- this somatic event. Then, using direct cDNA se- molog has been reported. For C. elegans, the phe- lection, a clone was isolated that mapped to the notype of mutants is also unknown. In both of candidate region. Translation of the DNA se- these cases, the homology shared with RecQ is quence of this clone revealed motifs homologous restricted to the seven conserved helicase motifs. to the RecQ/Sgsl helicase subfamily (Ellis et al. BLM is also homologous to Sgsl, a yeast pro- 1995a). tein (Gangloff et al. 1994). On the basis of a com- parison of their primary structure, four lines of BLM and Sgsl May Be Homologs evidence suggest that BLM may be the human homolog of Sgsl (see Fig. 1). First, unlike what is RecQ, the founding member of a subfamily of observed for RecQ and RECQL, the sequence sim- DNA helicases, is a DNA-dependent ATPase that ilarity between BLM and Sgsl extends beyond the possesses a 3' --4 5' DNA translocation activity. It helicase domains. Second, the size of the two pro- was first identified as a protein involved in the teins are nearly identical, more than twice the RecF recombination pathway in Escherichia coli size of the other RecQ family members. Third, the (Umezu et al. 1990). The absence of RecQ in E. conserved helicase domain is in the same posi- coli does not have any discernible phenotype un- tion in the two proteins, situated -700 amino less a major recombination pathway (RecBCD, acids from the amino terminus. Lastly, the SbcBC) is mutated (Clark 1991). In this situation, amino-terminal domain of BLM contains two loss of RecQ function leads to UV sensitivity and clusters of charged amino acid residues parallel- to a decrease in recombination. Recently, the ing the Sgsl organization. In addition to the RecQ subfamily of helicases has grown. A human structural similarities of BLM and Sgsl, blm and helicase, RECQL, was identified biochemically sgsl mutant cells both exhibit increased levels and was shown to possess the same in vitro prop- of mitotic recombination. In yeast cells, hyper- erties as bacterial RecQ (Puranam and Blackshear recombination is manifested by an increased 1994). Cloning and sequence analysis revealed frequency of marker loss. In Bloom's cells, it is revealed by increased sis- ter chromatid exchange RecQ and symmetrical quadr- iradials, which probably RECQL represent exchange fig- ures between homolo- Sgsl gous chromosomes in metaphase (German BLM 1964). On the other hand, recQ mutants ex- hibit decreased levels of Helicase domain recombination. Acidic amino acid cluster Extended homology Sgsl May Provide Clues to BLM Function Protein backbone with no homologies 200 AA First identified as an ex- Figure 1 Alignment representing the primary amino acid sequence of four mem- tragenic suppressor of the bers of the RecQ/Sgsl DNA helicase subfamily. The four proteins share strong sequence similarities within the region corresponding to the helicase domain. BLM slow-growth phenotype and Sgsl exhibit regions of homology directly surrounding the helicase domain, of topo Ill-deficient mu- which are not found within the other members of the subfamily. BLM and Sgsl also tants, the SGS1 locus was contain two clusters of acidic residues in their amino-terminal moieties that, in shown to interact physi- Sgsl, have been proposed to mediate transcriptional activation. cally with both topo II 422 ~ GENOME RESEARCH Downloaded from genome.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press MICROBIAL CLUES ABOUT CANCER PREDISPOSITION and topo III (Gangloff et al. 1994; Watt et al. crossover can become homozygous, resulting in 1995). As both of these DNA topoisomerases are loss of heterozygosity. potentially involved in the resolution of replica- tion intermediates (Wang 1991; Fig. 2), it is Hyper-recombinafion and Cancer tempting to speculate that Sgsl differentially modulates their activity. For example, in the ab- A few human disorders have been associated with sence of Sgsl, the failure to resolve the inter- increased levels of chromosomal rearrangements twined strands generated at the point where rep- (see Table 1). A common facet of these "hyper- lication forks merge would give rise to recombi- recombination" syndromes is their high cancer nogenic lesions (e.g., breaks) in a newly risk. Table 1 also lists selected genes from bacteria replicated chromatid. Repair of such lesions, us- and yeast that show increased recombination ing information from the sister chromatid, could (Hartwell and Smith 1985; Barnes et al. 1992; lead to a sister chromatid exchange event (Fig. Gangloff et al. 1994; Kato and Ogawa 1994; Mor- 3A). Alternatively, a cell could repair the dam- row et al. 1995; Savitsky et al. 1995; Smith and aged chromatid using information on the homol- Rothstein 1995). In bacteria, many of these genes ogous chromosome resulting in a mitotic ex- were identified using a simple assay in which re- change (Fig. 3B). In the mitotic division follow- combination between direct repeats leads to a se- ing such an exchange, DNA distal to the lectable phenotype (Konrad 1977). The fre- A topo II topo llI - Sgsl l Figure 2 Resolution of merging replicons. Two pathways have been proposed for the resolution of intertwined strands found at the site of merging replication forks (Wang 1991 ). As the two replicons approach one another, topological constraints block the merging forks leaving a small stretch of unreplicated duplex.
Recommended publications
  • Open Full Page
    CCR PEDIATRIC ONCOLOGY SERIES CCR Pediatric Oncology Series Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders Michael F. Walsh1, Vivian Y. Chang2, Wendy K. Kohlmann3, Hamish S. Scott4, Christopher Cunniff5, Franck Bourdeaut6, Jan J. Molenaar7, Christopher C. Porter8, John T. Sandlund9, Sharon E. Plon10, Lisa L. Wang10, and Sharon A. Savage11 Abstract DNA repair syndromes are heterogeneous disorders caused by around the world to discuss and develop cancer surveillance pathogenic variants in genes encoding proteins key in DNA guidelines for children with cancer-prone disorders. Herein, replication and/or the cellular response to DNA damage. The we focus on the more common of the rare DNA repair dis- majority of these syndromes are inherited in an autosomal- orders: ataxia telangiectasia, Bloom syndrome, Fanconi ane- recessive manner, but autosomal-dominant and X-linked reces- mia, dyskeratosis congenita, Nijmegen breakage syndrome, sive disorders also exist. The clinical features of patients with DNA Rothmund–Thomson syndrome, and Xeroderma pigmento- repair syndromes are highly varied and dependent on the under- sum. Dedicated syndrome registries and a combination of lying genetic cause. Notably, all patients have elevated risks of basic science and clinical research have led to important in- syndrome-associated cancers, and many of these cancers present sights into the underlying biology of these disorders. Given the in childhood. Although it is clear that the risk of cancer is rarity of these disorders, it is recommended that centralized increased, there are limited data defining the true incidence of centers of excellence be involved directly or through consulta- cancer and almost no evidence-based approaches to cancer tion in caring for patients with heritable DNA repair syn- surveillance in patients with DNA repair disorders.
    [Show full text]
  • EXTENDED CARRIER SCREENING Peace of Mind for Planned Pregnancies
    Focusing on Personalised Medicine EXTENDED CARRIER SCREENING Peace of Mind for Planned Pregnancies Extended carrier screening is an important tool for prospective parents to help them determine their risk of having a child affected with a heritable disease. In many cases, parents aren’t aware they are carriers and have no family history due to the rarity of some diseases in the general population. What is covered by the screening? Genomics For Life offers a comprehensive Extended Carrier Screening test, providing prospective parents with the information they require when planning their pregnancy. Extended Carrier Screening has been shown to detect carriers who would not have been considered candidates for traditional risk- based screening. With a simple mouth swab collection, we are able to test for over 419 genes associated with inherited diseases, including Fragile X Syndrome, Cystic Fibrosis and Spinal Muscular Atrophy. The assay has been developed in conjunction with clinical molecular geneticists, and includes genes listed in the NIH Genetic Test Registry. For a list of genes and disorders covered, please see the reverse of this brochure. If your gene of interest is not covered on our Extended Carrier Screening panel, please contact our friendly team to assist you in finding a gene test panel that suits your needs. Why have Extended Carrier Screening? Extended Carrier Screening prior to pregnancy enables couples to learn about their reproductive risk and consider a complete range of reproductive options, including whether or not to become pregnant, whether to use advanced reproductive technologies, such as preimplantation genetic diagnosis, or to use donor gametes.
    [Show full text]
  • CCR PEDIATRIC ONCOLOGY SERIES CCR Pediatric Oncology Series Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions Christopher C
    CCR PEDIATRIC ONCOLOGY SERIES CCR Pediatric Oncology Series Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions Christopher C. Porter1, Todd E. Druley2, Ayelet Erez3, Roland P. Kuiper4, Kenan Onel5, Joshua D. Schiffman6, Kami Wolfe Schneider7, Sarah R. Scollon8, Hamish S. Scott9, Louise C. Strong10, Michael F. Walsh11, and Kim E. Nichols12 Abstract Leukemia, the most common childhood cancer, has long been patients. The panel recognized that for several conditions, recognized to occasionally run in families. The first clues about routine monitoring with complete blood counts and bone the genetic mechanisms underlying familial leukemia emerged marrow evaluations is essential to identify disease evolution in 1990 when Li-Fraumeni syndrome was linked to TP53 muta- and enable early intervention with allogeneic hematopoietic tions. Since this discovery, many other genes associated with stem cell transplantation. However, for others, less intensive hereditary predisposition to leukemia have been identified. surveillance may be considered. Because few reports describ- Although several of these disorders also predispose individuals ing the efficacy of surveillance exist, the recommendations to solid tumors, certain conditions exist in which individuals are derived by this panel are based on opinion, and local expe- specifically at increased risk to develop myelodysplastic syn- rience and will need to be revised over time. The development drome (MDS) and/or acute leukemia. The increasing identifica- of registries and clinical trials is urgently needed to enhance tion of affected individuals and families has raised questions understanding of the natural history of the leukemia-predis- around the efficacy, timing, and optimal methods of surveil- posing conditions, such that these surveillance recommenda- lance.
    [Show full text]
  • Transcriptome Analyses of Rhesus Monkey Pre-Implantation Embryos Reveal A
    Downloaded from genome.cshlp.org on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press Transcriptome analyses of rhesus monkey pre-implantation embryos reveal a reduced capacity for DNA double strand break (DSB) repair in primate oocytes and early embryos Xinyi Wang 1,3,4,5*, Denghui Liu 2,4*, Dajian He 1,3,4,5, Shengbao Suo 2,4, Xian Xia 2,4, Xiechao He1,3,6, Jing-Dong J. Han2#, Ping Zheng1,3,6# Running title: reduced DNA DSB repair in monkey early embryos Affiliations: 1 State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, China 2 Key Laboratory of Computational Biology, CAS Center for Excellence in Molecular Cell Science, Collaborative Innovation Center for Genetics and Developmental Biology, Chinese Academy of Sciences-Max Planck Partner Institute for Computational Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China 3 Yunnan Key Laboratory of Animal Reproduction, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, China 4 University of Chinese Academy of Sciences, Beijing, China 5 Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming, Yunnan 650204, China 6 Primate Research Center, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China * Xinyi Wang and Denghui Liu contributed equally to this work 1 Downloaded from genome.cshlp.org on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press # Correspondence: Jing-Dong J. Han, Email: [email protected]; Ping Zheng, Email: [email protected] Key words: rhesus monkey, pre-implantation embryo, DNA damage 2 Downloaded from genome.cshlp.org on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press ABSTRACT Pre-implantation embryogenesis encompasses several critical events including genome reprogramming, zygotic genome activation (ZGA) and cell fate commitment.
    [Show full text]
  • Disease Reference Book
    The Counsyl Foresight™ Carrier Screen 180 Kimball Way | South San Francisco, CA 94080 www.counsyl.com | [email protected] | (888) COUNSYL The Counsyl Foresight Carrier Screen - Disease Reference Book 11-beta-hydroxylase-deficient Congenital Adrenal Hyperplasia .................................................................................................................................................................................... 8 21-hydroxylase-deficient Congenital Adrenal Hyperplasia ...........................................................................................................................................................................................10 6-pyruvoyl-tetrahydropterin Synthase Deficiency ..........................................................................................................................................................................................................12 ABCC8-related Hyperinsulinism........................................................................................................................................................................................................................................ 14 Adenosine Deaminase Deficiency .................................................................................................................................................................................................................................... 16 Alpha Thalassemia.............................................................................................................................................................................................................................................................
    [Show full text]
  • Arsenic Disruption of DNA Damage Responses—Potential Role in Carcinogenesis and Chemotherapy
    Biomolecules 2015, 5, 2184-2193; doi:10.3390/biom5042184 OPEN ACCESS biomolecules ISSN 2218-273X www.mdpi.com/journal/biomolecules/ Review Arsenic Disruption of DNA Damage Responses—Potential Role in Carcinogenesis and Chemotherapy Clarisse S. Muenyi 1, Mats Ljungman 2 and J. Christopher States 3,* 1 Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40292, USA; E-Mail: [email protected] 2 Departments of Radiation Oncology and Environmental Health Sciences, University of Michigan, Ann Arbor, MI 48109-2800, USA; E-Mail: [email protected] 3 Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40292, USA * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-502-852-5347; Fax: +1-502-852-3123. Academic Editors: Wolf-Dietrich Heyer, Thomas Helleday and Fumio Hanaoka Received: 14 August 2015 / Accepted: 9 September 2015 / Published: 24 September 2015 Abstract: Arsenic is a Class I human carcinogen and is widespread in the environment. Chronic arsenic exposure causes cancer in skin, lung and bladder, as well as in other organs. Paradoxically, arsenic also is a potent chemotherapeutic against acute promyelocytic leukemia and can potentiate the cytotoxic effects of DNA damaging chemotherapeutics, such as cisplatin, in vitro. Arsenic has long been implicated in DNA repair inhibition, cell cycle disruption, and ubiquitination dysregulation, all negatively impacting the DNA damage response and potentially contributing to both the carcinogenic and chemotherapeutic potential of arsenic. Recent studies have provided mechanistic insights into how arsenic interferes with these processes including disruption of zinc fingers and suppression of gene expression.
    [Show full text]
  • Blueprint Genetics Ectodermal Dysplasia Panel
    Ectodermal Dysplasia Panel Test code: DE0401 Is a 25 gene panel that includes assessment of non-coding variants. Is ideal for patients with a clinical suspicion of ectodermal dysplasia (hidrotic or hypohidrotic) or Ellis-van Creveld syndrome. About Ectodermal Dysplasia Ectodermal Dysplasia (ED) is a group of closely related conditions of which more than 150 different syndromes have been identified. EDs affects the development or function of teeth, hair, nails and sweat glands. ED may present as isolated or as part of a syndromic disease and is commonly subtyped according to sweating ability. The clinical features of the X-linked and autosomal forms of hypohidrotic ectodermal dysplasia (HED) can be indistinguishable and many of the involved genes may lead to phenotypically distinct outcomes depending on number of defective alleles. The most common EDs are hypohidrotic ED and hydrotic ED. X-linked hypohidrotic ectodermal dysplasia (HED) is caused by EDA mutations and explain 75%-95% of familial HED and 50% of sporadic cases. HED is characterized by three cardinal features: hypotrichosis (sparse, slow-growing hair and sparse/missing eyebrows), reduced sweating and hypodontia (absence or small teeth). Reduced sweating poses risk for episodes of hyperthermia. Female carriers may have some degree of hypodontia and mild hypotrichosis. Isolated dental phenotypes have also been described. Mutations in WNT10A have been reported in up to 9% of individuals with HED and in 25% of individuals with HED who do not have defective EDA. Approximately 50% of individuals with heterozygous WNT10A mutation have HED and the most consistent clinical feature is severe oligodontia of permanent teeth.
    [Show full text]
  • Epigenetic Regulation of DNA Repair Genes and Implications for Tumor Therapy ⁎ ⁎ Markus Christmann , Bernd Kaina
    Mutation Research-Reviews in Mutation Research xxx (xxxx) xxx–xxx Contents lists available at ScienceDirect Mutation Research-Reviews in Mutation Research journal homepage: www.elsevier.com/locate/mutrev Review Epigenetic regulation of DNA repair genes and implications for tumor therapy ⁎ ⁎ Markus Christmann , Bernd Kaina Department of Toxicology, University of Mainz, Obere Zahlbacher Str. 67, D-55131 Mainz, Germany ARTICLE INFO ABSTRACT Keywords: DNA repair represents the first barrier against genotoxic stress causing metabolic changes, inflammation and DNA repair cancer. Besides its role in preventing cancer, DNA repair needs also to be considered during cancer treatment Genotoxic stress with radiation and DNA damaging drugs as it impacts therapy outcome. The DNA repair capacity is mainly Epigenetic silencing governed by the expression level of repair genes. Alterations in the expression of repair genes can occur due to tumor formation mutations in their coding or promoter region, changes in the expression of transcription factors activating or Cancer therapy repressing these genes, and/or epigenetic factors changing histone modifications and CpG promoter methylation MGMT Promoter methylation or demethylation levels. In this review we provide an overview on the epigenetic regulation of DNA repair genes. GADD45 We summarize the mechanisms underlying CpG methylation and demethylation, with de novo methyl- TET transferases and DNA repair involved in gain and loss of CpG methylation, respectively. We discuss the role of p53 components of the DNA damage response, p53, PARP-1 and GADD45a on the regulation of the DNA (cytosine-5)- methyltransferase DNMT1, the key enzyme responsible for gene silencing. We stress the relevance of epigenetic silencing of DNA repair genes for tumor formation and tumor therapy.
    [Show full text]
  • Expression of MSH2 and MSH6 on a Tissue Microarray in Patients with Osteosarcoma
    ANTICANCER RESEARCH 34: 6961-6972 (2014) Expression of MSH2 and MSH6 on a Tissue Microarray in Patients with Osteosarcoma THORSTEN JENTZSCH1,2, BERNHARD ROBL1, MAREN HUSMANN1, BEATA BODE-LESNIEWSKA3 and BRUNO FUCHS1 1Laboratory for Orthopedic Research, Department of Orthopedics, Balgrist University Hospital, Zürich, Switzerland; 2Division of Trauma Surgery, Department of Surgery, University Hospital Zürich, Zürich, Switzerland; 3Institute of Surgical Pathology, University Hospital Zürich, Zürich, Switzerland Abstract. Background/Aim: Reliable prognostic factors for and head (4, 5). Following neoadjuvant chemotherapy, surgical the outcome of patients with osteosarcoma (OS) remain elusive. tumor resections provide tissue specimens for the assessment We analyzed the relationship between immunohistochemical of tumor necrosis rate, histology, grading and evaluation of expression of deoxyribonucleic acid (DNA) mismatch repair tumor biomarkers before further adjuvant chemotherapy may (MMR) proteins, MutS protein homolog 2 (MSH2) and MSH6 be initiated (6-8). Despite advances in therapeutic approaches, using a tissue microarray (TMA) with respect to OS patient five-year overall survival rates have been reported as 78% (9) demographics and survival time. Materials and Methods: We and are usually lower for non-responders to chemotherapy retrieved tumor tissue specimens from bone tissue originating (10) and patients with metastasis (11, 12). from surgical primary tumor specimens of OS patients to Albeit the limited number of studies (8, 13-17) on tumor generate a TMA and stained sections with antibodies against biomarkers, these are important for treatment decisions, MSH2 and MSH6. Results: Tumor resections of 67 patients patient discrimination regarding the response to with a mean follow-up of 98 months were evaluated. MSH2 chemotherapy and the incidence of metastasis, prediction of was expressed in nine (13%), MSH6 in ten (15%) and patient survival times and patient education (18-21).
    [Show full text]
  • Xeroderma Pigmentosum
    Xeroderma pigmentosum Description Xeroderma pigmentosum, which is commonly known as XP, is an inherited condition characterized by an extreme sensitivity to ultraviolet (UV) rays from sunlight. This condition mostly affects the eyes and areas of skin exposed to the sun. Some affected individuals also have problems involving the nervous system. The signs of xeroderma pigmentosum usually appear in infancy or early childhood. Many affected children develop a severe sunburn after spending just a few minutes in the sun. The sunburn causes redness and blistering that can last for weeks. Other affected children do not get sunburned with minimal sun exposure, but instead tan normally. By age 2, almost all children with xeroderma pigmentosum develop freckling of the skin in sun-exposed areas (such as the face, arms, and lips); this type of freckling rarely occurs in young children without the disorder. In affected individuals, exposure to sunlight often causes dry skin (xeroderma) and changes in skin coloring (pigmentation). This combination of features gives the condition its name, xeroderma pigmentosum. People with xeroderma pigmentosum have a greatly increased risk of developing skin cancer. Without sun protection, about half of children with this condition develop their first skin cancer by age 10. Most people with xeroderma pigmentosum develop multiple skin cancers during their lifetime. These cancers occur most often on the face, lips, and eyelids. Cancer can also develop on the scalp, in the eyes, and on the tip of the tongue. Studies suggest that people with xeroderma pigmentosum may also have an increased risk of other types of cancer, including brain tumors.
    [Show full text]
  • Blueprint Genetics Bone Marrow Failure Syndrome Panel
    Bone Marrow Failure Syndrome Panel Test code: HE0801 Is a 135 gene panel that includes assessment of non-coding variants. Is ideal for patients with a clinical suspicion of inherited bone marrow failure syndromes. The genes on this panel are included in the Comprehensive Hematology Panel. About Bone Marrow Failure Syndrome Inherited bone marrow failure syndromes (IBMFS) are a diverse set of genetic disorders characterized by the inability of the bone marrow to produce sufficient circulating blood cells. Bone marrow failure can affect all blood cell lineages causing clinical symptoms similar to aplastic anemia, or be restricted to one or two blood cell lineages. The clinical presentation may include thrombocytopenia or neutropenia. Hematological manifestations may be accompanied by physical features such as short stature and abnormal skin pigmentation in Fanconi anemia and dystrophic nails, lacy reticular pigmentation and oral leukoplakia in dyskeratosis congenita. Patients with IBMFS have an increased risk of developing cancer—either hematological or solid tumors. Early and correct disease recognition is important for management and surveillance of the diseases. Currently, accurate genetic diagnosis is essential to confirm the clinical diagnosis. The most common phenotypes that are covered by the panel are Fanconi anemia, Diamond-Blackfan anemia, dyskeratosis congenita, Shwachman-Diamond syndrome and WAS-related disorders. Availability 4 weeks Gene Set Description Genes in the Bone Marrow Failure Syndrome Panel and their clinical significance
    [Show full text]
  • Pediatric Photosensitivity Disorders Dr
    FAST FACTS FOR BOARD REVIEW Series Editor: William W. Huang,MD,MPH W. Series Editor:William Swetha N.Pathak,MD;JacquelineDeLuca,MD Pediatric PhotosensitivityDisorders Table 1. Pediatric Photosensitivity Disorders Disease Pathophysiology Clinical Features Management/Prognosis Other/Pearls Actinic prurigo Strong association Pruritic crusted papules Phototesting: lesions Native Americans, (hydroa aestivale, with HLA-DR4 and nodules in both provoked by UVA or UVB; especially mestizos; Hutchinson (HLA-DRB1*0401/0407); sun-exposed and less spontaneous resolution hardening does not summer prurigo) may be a persistent frequently nonexposed may occur during late occur; histopathology: variant of PMLE sites (ie, buttocks); heal adolescence; may follow dermal perivascular (delayed-type with scarring; mucosal a chronic course that mononuclear cell hypersensitivity) and conjunctival persists in adulthood; infiltrate, lacks papillary from UVA or UVB involvement, with cheilitis photoprotection; topical dermal edema, can see often an initial or only corticosteroids and lymphoid follicles feature; worse in summer topical tacrolimus; from lip biopsies; but can extend to winter NB-UVB or PUVA; occurs hours to cyclosporine or days following azathioprine; thalidomide sun exposure (treatment of choice) for (vs solar urticaria) resistant disease noconflictofinterest. The authorsreport Long Beach,California. Center, LaserSkinCare DeLucaisfrom Dr. North Carolina. Winston-Salem, University, Forest Wake Pathakisfrom Dr. Bloom syndrome AR; BLM (encodes Malar telangiectatic
    [Show full text]